Ranjeet Ajmani: Southeast Asia – 25% of The Global Population Contributes Less than 2% of The Global Plasma Supply
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn:
”It will be an honor to share experiences and insights at the Business Forum (October, 16, 2025) of the Plasma Protein Therapeutics Association (PPTA), Virginia, USA
Southeast Asia (SEA), home to over 2 billion people—about 25% of the global population—contributes less than 2% of the global plasma supply.
This disparity is clearly reflected in patient care, particularly in the availability, accessibility, and affordability of Plasma-Derived Medicinal Products (PDMPs).
The situation is further exacerbated by limited public healthcare expenditure, inadequate health policies, and regulatory challenges.
As a result, a vast majority of patients in developing countries remain undiagnosed.
Many live with serious, yet treatable, conditions—often in silence, suffering without support, and sadly passing away without ever receiving the care they need.
These stories are not just statistics—they are deeply human, and often heart-wrenching.
We must ask ourselves: Can we do more for our fellow citizens?
The answer must be yes.
By fostering collaboration across governments, regulators, industry, and patient advocacy groups, and by reimagining policies and infrastructure, we can build a more equitable future—one in which no one is left behind simply because of where they were born.”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 14:51Mavis Agnes Kisakye: Reconnecting to Drive the Global Bleeding Disorders Agenda Forward
-
Apr 22, 2026, 14:48Augustina Isioma Ikusemoro: Not Every Antigen Speaks Loudly But the Right Test Will Hear It
-
Apr 22, 2026, 14:47Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
-
Apr 22, 2026, 14:46David Brown: Charting a New Path Forward for One Patient Facing Extraordinary Cardiac Challenges
-
Apr 22, 2026, 14:45Ney Carter Borges: Syphilis and Cardiovascular Risk – A Silent and Progressive Vascular Burden
-
Apr 22, 2026, 14:44Sanjay Ahuja – New CEO and Medical Director of Innovative Hematology
-
Apr 22, 2026, 14:36Shivanand Kumatagi: Building Clinical Research Skills at the ASH CRTI Asia Pacific Program
-
Apr 22, 2026, 14:22Pradeep Natarajan: Can Polygenic Risk Scores Refine Risk Stratification in Secondary Prevention of CAD
-
Apr 22, 2026, 14:16Omar Adwan: Rare Genetic Disorders of Red Blood Cell Membrane Abnormalities